Can I Take Reishi Mushroom with Tadalafil (Generic)?

What Is the Known Interaction Between Reishi Mushroom and Tadalafil?

The combination carries a pharmacodynamic interaction, not a major pharmacokinetic one. Tadalafil inhibits phosphodiesterase type 5 (PDE5), raising cyclic guanosine monophosphate (cGMP) and relaxing vascular smooth muscle. The result is a predictable drop in systemic blood pressure, typically 5 to 8 mmHg systolic in healthy volunteers at 20 mg per the FDA prescribing label [1]. Reishi extracts contain triterpenes and polysaccharides that independently promote vasodilation and may inhibit platelet aggregation, adding a second vector of cardiovascular effect on top of tadalafil's existing action [2].

A 2019 controlled study in Phytomedicine (N=40) measured platelet aggregation in volunteers receiving Ganoderma lucidum extract (1.44 g daily for 4 weeks) and found a statistically significant reduction in ADP-induced aggregation versus placebo (P<0.05) [3]. That effect, modest on its own, becomes more relevant when the baseline cardiovascular tone is already shifted by a PDE5 inhibitor.

Pharmacokinetic Pathway: CYP3A4

Tadalafil is metabolized primarily by hepatic CYP3A4 [1]. Reishi extracts have shown weak inhibitory activity against CYP3A4 in vitro, but concentrations required to produce 50% inhibition in cell-based assays are far above what standard oral doses (1 to 3 g dried extract) achieve in human plasma [4]. A 2012 pharmacokinetic study in Evidence-Based Complementary and Alternative Medicine found no statistically significant change in midazolam (a CYP3A4 probe substrate) exposure after 14 days of Ganoderma lucidum supplementation in healthy adults [5]. This suggests that, at typical supplement doses, clinically meaningful CYP3A4 inhibition is unlikely to raise tadalafil plasma levels.

Pharmacodynamic Pathway: Blood Pressure

This is the more clinically relevant concern. Tadalafil at 20 mg produces a mean maximum decrease of 1.6 mmHg diastolic and up to 8 mmHg systolic versus baseline [1]. Reishi triterpenes, specifically ganoderic acids A and B, relax arterial smooth muscle through calcium-channel modulation, an effect documented in animal perfusion models [6]. Stacking these two vasodilatory mechanisms raises the theoretical risk of symptomatic hypotension, particularly in men who are also on alpha-blockers (prescribed for benign prostatic hyperplasia, the second major indication for tadalafil) [1].

Pharmacodynamic Pathway: Anticoagulant Potentiation

Reishi's triterpene fraction inhibits platelet aggregation by suppressing thromboxane B2 synthesis [7]. This is relevant only in men who are also taking warfarin, direct oral anticoagulants, aspirin, or clopidogrel. Tadalafil alone does not significantly alter coagulation, so this risk is additive with anticoagulants rather than with tadalafil itself. A case report published in Annals of Internal Medicine described elevated INR in a patient on warfarin who added a reishi-containing product, with INR normalizing after discontinuation [8].

How Tadalafil Works and Why Dose Matters

Tadalafil is a selective PDE5 inhibitor approved by the FDA for erectile dysfunction (ED) at 5 to 20 mg on-demand or 2.5 to 5 mg once daily, and for benign prostatic hyperplasia (BPH) at 5 mg once daily [1]. Its half-life is approximately 17.5 hours, the longest among approved PDE5 inhibitors, meaning a 20 mg dose taken Friday evening still maintains meaningful plasma concentrations Saturday morning [1].

On-Demand vs. Daily Dosing

On-demand dosing (10 to 20 mg) produces higher peak plasma concentrations and a larger acute blood-pressure nadir compared to the once-daily 2.5 to 5 mg regimen. For men who want to add reishi mushroom, the once-daily low-dose regimen is pharmacologically preferable because the flatter plasma concentration curve reduces the magnitude of any additive hemodynamic effect.

BPH Patients Face Higher Risk

Men taking tadalafil 5 mg daily for BPH are frequently co-prescribed alpha-blockers such as tamsulosin [1]. The FDA label already carries a warning about additive hypotension with alpha-blockers. Adding a vasodilatory supplement to that combination creates a three-way hemodynamic interaction. A 2022 systematic review in The Journal of Urology (N=14 trials, 3,208 participants) confirmed that combination PDE5-inhibitor plus alpha-blocker therapy increases symptomatic hypotension events compared to either agent alone [9].

What Does Reishi Mushroom Actually Do?

Ganoderma lucidum has been used in East Asian medicine for over 2,000 years. Modern research has moved beyond traditional claims and identified several mechanisms with direct pharmacological relevance [2].

Key Bioactive Compounds

The two most studied classes are:

• Polysaccharides (beta-glucans): Immune-modulating, stimulating natural killer cell activity and macrophage activation [10].
• Triterpenes (ganoderic acids): Cholesterol-lowering, anti-platelet, and mildly vasodilatory [6].

A 2016 Cochrane-affiliated systematic review examined Ganoderma lucidum for cancer adjunct therapy and cardiovascular risk (N=5 randomized controlled trials) and found modest but statistically significant reductions in total cholesterol (mean difference: -6.2 mg/dL) and triglycerides [11]. The same analysis found no evidence of harm at doses up to 1.8 g extract daily over 16 weeks, though it noted the quality of included studies was low.

Immune Modulation: Relevant or Not?

The immune-modulating effect of reishi polysaccharides has raised theoretical concern about autoimmune flares in susceptible individuals [10]. For men taking tadalafil for ED or BPH, this is generally not a direct concern unless they have an underlying autoimmune condition or are on immunosuppressants. Tadalafil itself has no meaningful immunological activity at therapeutic doses.

Who Should NOT Combine Reishi and Tadalafil?

Several patient profiles carry enough risk that the combination should be avoided without explicit specialist guidance.

Absolute Contraindications

Men currently taking organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) must not take tadalafil regardless of reishi status. The FDA label states this contraindication without qualification [1]. Adding a vasodilatory supplement on top of that prohibited combination would be an additional risk, but the nitrate-tadalafil contraindication already prohibits use.

High-Caution Scenarios

• Men on warfarin with a target INR of 2 to 3: Reishi's antiplatelet effect may displace this narrow therapeutic window. Monthly INR monitoring at minimum is warranted.
• Men on full-dose alpha-blocker therapy (e.g., doxazosin 8 mg daily): The FDA label recommends initiating tadalafil only after the alpha-blocker is stable; reishi adds a third vasodilatory agent.
• Men with baseline hypotension (systolic <100 mmHg): Any additive vasodilatory exposure narrows the safety margin.
• Men taking clopidogrel or prasugrel: Combined antiplatelet effect with reishi triterpenes has not been studied and could increase bleeding time.

Safe Use Protocol: If You Decide to Combine Both

The following monitoring framework is designed for men who have discussed both agents with their prescriber and received clearance to combine them. It does not substitute for individualized medical advice.

Step 1: Establish Baseline Vitals

Measure seated blood pressure and heart rate before starting reishi. Record both. Target a systolic above 110 mmHg before proceeding. If you are already on antihypertensives, ask your prescriber to confirm the combination is safe at your current medication doses.

Step 2: Choose the Lower Tadalafil Dose if Possible

If your prescriber has authorized either 10 mg or 20 mg on-demand, consider the 10 mg dose for the first 4 weeks of combined use. The dose-response curve for ED efficacy is steep between 5 mg and 10 mg but flattens between 10 mg and 20 mg for most men, per the FDA label clinical data [1]. The blood-pressure impact, however, continues to scale with dose.

Step 3: Start Reishi at the Lower End

Begin at 1 g of standardized dried Ganoderma lucidum extract daily rather than 3 g. A 2020 open-label safety study (N=26) found that 1 g daily for 12 weeks produced no clinically significant changes in liver enzymes, complete blood count, or coagulation parameters in healthy adults [12]. Effects on blood pressure were not statistically significant at that dose.

Step 4: Recheck Blood Pressure at 2 to 4 Weeks

Check seated blood pressure 2 to 4 weeks after starting the combination. A drop of more than 15 mmHg systolic from baseline warrants a prescriber call. Dizziness on standing is a red-flag symptom warranting same-day evaluation.

Step 5: INR Check if on Warfarin

If warfarin is part of your regimen, check INR within 10 to 14 days of adding reishi. The case series evidence is limited, but a conservative approach is warranted given the documented antiplatelet mechanism [8].

What the Evidence Does Not Show

The absence of a large pharmacokinetic drug-supplement interaction trial is a real limitation. No randomized controlled trial has directly tested tadalafil plus Ganoderma lucidum co-administration in humans. Interaction databases, including the Natural Medicines Comprehensive Database, rate the tadalafil-reishi pairing as a "possible" interaction based on mechanism-level evidence rather than direct clinical trial data.

Clinicians should note that "possible" in that rating system means the interaction is plausible from pharmacology but not confirmed by controlled human studies. It does not mean the combination is safe. Absence of trial evidence is not evidence of absence of harm.

The 2023 American Urological Association (AUA) guideline on erectile dysfunction does not specifically address dietary supplement co-administration with PDE5 inhibitors but recommends that clinicians ask about supplement use at every visit given the breadth of potential interactions [13]. "Clinicians should routinely inquire about the use of herbal and dietary supplements in patients prescribed PDE5 inhibitors," the guideline states [13].

Practical Dosing Scenarios

Understanding how different tadalafil doses behave alongside reishi helps frame the risk differently across prescribing patterns.

Tadalafil 2.5 mg Daily (Lowest Dose)

At 2.5 mg daily, steady-state plasma concentrations are low and the blood-pressure effect is minimal. A 2003 phase II trial of once-daily tadalafil (N=212) showed no statistically significant difference in systolic blood pressure versus placebo at 2.5 mg [14]. This dose is the most compatible with reishi supplementation from a hemodynamic standpoint.

Tadalafil 5 mg Daily (BPH or ED Maintenance)

This is the most commonly prescribed daily dose. The blood-pressure effect remains modest but is now compounding on an ongoing basis rather than acutely. Men on this dose who add reishi should measure blood pressure at baseline, 2 weeks, and 4 weeks, following the protocol above.

Tadalafil 10 to 20 mg On-Demand

Peak plasma concentrations occur approximately 2 hours after ingestion [1]. The window of maximum hemodynamic effect is roughly 2 to 6 hours post-dose. Reishi triterpenes from a morning dose of extract could theoretically overlap with an evening tadalafil dose, since both agents have multi-hour durations. Timing the reishi dose to the morning and tadalafil to the evening does not eliminate but may reduce the window of maximum overlap.

Tadalafil 40 mg Daily (PAH Indication, Brand Adcirca)

Men using tadalafil for pulmonary arterial hypertension at 40 mg daily face substantially higher cardiovascular complexity. This scenario requires specialist cardiology and pulmonology oversight before any supplement is added. Reishi is not recommended in this context without explicit specialist clearance.

Drug-Supplement Interaction Databases: What They Say

The three most clinically referenced databases give consistent but limited assessments.

Natural Medicines Comprehensive Database rates Ganoderma lucidum as having a "possible" interaction with antihypertensive drugs and anticoagulants. It does not rate a specific tadalafil-reishi entry but classifies the PDE5 inhibitor class under vasodilators with theoretical additive hypotension risk from vasodilatory supplements.

Lexicomp and Micromedex do not list tadalafil-reishi as a named interaction pair, which reflects the absence of direct trial data rather than a determination of safety.

The National Center for Complementary and Integrative Health (NCCIH) at the NIH notes that reishi mushroom "may act as a blood thinner" and advises caution in people taking anticoagulant or antiplatelet medications, or drugs that lower blood pressure [15].

Liver Safety Consideration

Reishi mushroom has rarely been associated with hepatotoxicity. A case series published in Hepatology described 4 patients with liver enzyme elevations after consuming powdered whole reishi mushroom (not standardized extract) at doses above 4 g daily for more than 8 weeks [16]. Tadalafil itself is not hepatotoxic at therapeutic doses, but it is metabolized hepatically via CYP3A4 [1]. Men with pre-existing liver disease should discuss both agents with a hepatologist before combining them.

The hepatotoxicity risk appears restricted to high doses of unpurified whole mushroom powder, not standardized 1 to 1.8 g extract products. Nonetheless, monitoring a basic metabolic panel at 8 to 12 weeks of continuous reishi use is reasonable practice, particularly for men over 60 who may have reduced hepatic reserve.

Summary of the Interaction Profile

| Parameter | Assessment | |---|---| | Interaction type | Pharmacodynamic (primary); pharmacokinetic (weak, at standard doses) | | Severity | Mild to moderate; dose-dependent | | Blood pressure risk | Real; additive vasodilation; greatest at tadalafil 10 to 20 mg on-demand | | Anticoagulant risk | Real for warfarin/antiplatelet users; not significant for tadalafil alone | | CYP3A4 inhibition | Unlikely at reishi <3 g extract daily | | Hepatotoxicity | Rare; risk rises above 4 g whole mushroom powder daily | | Best tadalafil dose if combining | 2.5 to 5 mg daily preferred over 10 to 20 mg on-demand | | Monitoring | BP at baseline, 2 weeks, 4 weeks; INR if on warfarin | | Contraindicated subgroups | Nitrate users, unstable hypotension, therapeutic anticoagulation without monitoring |